Gammadelta T Cells: Innately adaptive immune cells

International Reviews of Immunology

Volumn 32, Issue 3, 2013, Pages 223-248

  Ferreira, Leonardo M R ^a  

^a Harvard University   (United States)

Author keywords

T cell; Ligand diversity; T cell development; TCR structure; Tissue specific T cells

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN; HLA A24 ANTIGEN; HLA B27 ANTIGEN; HLA E ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 4; ISOPENTENYL DIPHOSPHATE; PROTEIN KINASE ZAP 70; RECOMBINASE; SOMATOMEDIN C; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; VIRUS PROTEIN; ZOLEDRONIC ACID;

ADAPTIVE IMMUNITY; ARTICLE; BACTERIAL INFECTION; BREAST CANCER; BREAST TUMOR; CANCER IMMUNOTHERAPY; CANCER PATIENT; CASTRATION RESISTANT PROSTATE CANCER; CELL INTERACTION; CELL MATURATION; CELL PROLIFERATION; CELL SURFACE; CELLULAR IMMUNITY; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY; DAUDI CELL; DENDRITIC CELL; DIGEORGE SYNDROME; ENDOMETRIUM; EPITHELIUM TUMOR; EXTRACELLULAR MATRIX; FETUS LIVER; GAMMA DELTA T LYMPHOCYTE; GENE REARRANGEMENT; HUMAN; HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA; INTESTINE MUCOSA; INTRACELLULAR BACTERIUM; KIDNEY GRAFT; LISTERIA MONOCYTOGENES; LISTERIOSIS; LYMPHOID ORGAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROBIAL DEGRADATION; MITOTIC RECOMBINATION; NATURAL KILLER CELL; NATURAL KILLER T CELL; NIDATION; NIPPOSTRONGYLUS BRASILIENSIS; NONHUMAN; ONTOGENY; OSTEOPOROSIS; PERIPHERAL LYMPHOCYTE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHENOTYPE; PLASMODIUM YOELII; POPULATION SIZE; PRE T LYMPHOCYTE; PREGNANCY; PREGNANCY TERMINATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN QUATERNARY STRUCTURE; RODENT MALARIA; SPOROZOITE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; TUMOR MODEL; VDJ RECOMBINATION; WOUND CLOSURE; WOUND HEALING;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, BACTERIAL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY, INNATE; IMMUNOMODULATION; MICE; ORGAN SPECIFICITY; PREGNANCY; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 84879101768     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830185.2013.783831     Document Type: Article

References (235)

1. Allison JP, McIntyre BW, Bloch D. Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody. J Immunol 1982;129(5):2293-2300.
2. Garboczi DN, Ghosh P, Utz U, et al. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 1996;384(6605):134-141.
3. Garcia KC, Degano M, Stanfield RL, et al. An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 1996;274(5285):209-219.
4. Wucherpfennig KW. The first structures of T cell receptors bound to peptide-MHC. J Immunol 2010;185(11):6391-6393.
5. Wucherpfennig KW, Gagnon E, CallMJ, et al. Structural biology of the T-cell receptor: insights into receptor assembly, ligand recognition, and initiation of signaling. Cold Spring Harb Perspect Biol 2010;2(4):a005140.
6. Lanier LL. First sighting of the elusive T cell antigen receptor. J Immunol 2005;174(3):1143.
7. Moon JJ, Chu HH, PepperM, et al. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and responsemagnitude. Immunity 2007;27(2):203-213.
8. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature 1988;334(6181):395-402.
9. Davis MM, Lindsten T, Gascoigne NR, et al. T-cell receptor gene structure and function. Cell Immunol 1986;99(1):24-28.
10. Satyanarayana K, Hata S, Devlin P, et al. Genomic organization of the human T-cell antigenreceptor alpha/delta locus. Proc Natl Acad Sci USA 1988;85(21):8166-8170.
11. HaydayAC. [gamma] [delta] cells: a right time and a right place for a conserved thirdway of protection. Annu Rev Immunol 2000;18:975-1026.
12. Saito H, Kranz DM, Takagaki Y, et al. A third rearranged and expressed gene in a clone of cytotoxic T lymphocytes. Nature 1984;312(5989):36-40.
13. MurreC,Waldmann RA,Morton CC, et al.Human gamma-chain genes are rearranged in leukaemic T cells andmap to the short armof chromosome 7. Nature 1985;316(6028):549-552.
14. BrennerMB,McLean J, Dialynas DP, et al. Identification of a putative second T-cell receptor.Nature 1986;322(6075):145-149.
15. Loh EY, Lanier LL, Turck CW, et al. Identification and sequence of a fourth human T cell antigen receptor chain. Nature 1987;330(6148):569-572.
16. Born W, Miles C, White J, et al. Peptide sequences of T-cell receptor delta and gamma chains are identical to predicted X and gamma proteins. Nature 1987;330(6148):572-574.
17. Allison TJ, Winter CC, Fournie JJ, et al. Structure of a human gammadelta T-cell antigen receptor. Nature 2001;411(6839):820-824.
18. Adams EJ, Chien YH, Garcia KC. Structure of a gammadelta T cell receptor in complex with the nonclassicalMHC T22. Science 2005;308(5719):227-231.
19. Meuer SC, FitzgeraldKA,HusseyRE, et al.Clonotypic structures involved inantigen-specifichuman T cell function. Relationship to the T3 molecular complex. J ExpMed 1983;157(2):705-719.
20. Haskins K, Kubo R,White J, et al.Themajor histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with amonoclonal antibody. J ExpMed 1983;157(4):1149-1169.
21. Samelson LE, Germain RN, Schwartz RH.Monoclonal antibodies against the antigen receptor on a cloned T-cell hybrid. Proc Natl Acad Sci USA 1983;80(22):6972-6976.
22. Yanagi Y, Yoshikai Y, Leggett K, et al. A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains. Nature 1984;308(5955):145-149.
23. Bosnes V, Qvigstad E, Lundin KE,Thorsby E. Recognition of a particular HLA-DQ heterodimer by a human gamma/delta T cell clone. Eur J Immunol 1990;20(7):1429-1433.
24. Tanaka Y, Sano S,Nieves E, et al.Nonpeptide ligands for human gamma delta T cells. ProcNatl Acad Sci USA 1994;91(17):8175-8179.
25. Xu B, Pizarro JC,Holmes MA, et al. Crystal structure of a gammadelta T-cell receptor specific for the humanMHC class I homolog MICA. Proc Natl Acad Sci USA 2011;108(6):2414-2419.
26. Strominger JL. Developmental biology of T cell receptors. Science 1989;244(4907):943-950.
27. Allison JP,Havran WL.Theimmunobiology of T cellswith invariant gamma delta antigen receptors. Annu Rev Immunol 1991;9:679-705.
28. Havran WL, Allison JP. Developmentally ordered appearance of thymocytes expressing different T cell antigen receptors. Nature 1988;335:443-445.
29. Asarnow DM, Goodman T, LeFrancois L, Allison JP. Distinct antigen receptor repertoires of two classes ofmurine epithelium-associated T cells. Nature 1989;341(6237):60-62.
30. Chien YH, Jores R, Crowley MP. Recognition by gamma/delta T cells. Annu Rev Immunol 1996;14:511-532.
31. McVay LD, Jaswal SS, Kennedy C, et al. The generation of human gammadelta T cell repertoires during fetal development. J Immunol 1998;160(12):5851-5860.
32. Korman AJ, Marusic-Galesic S, Spencer D, et al. Predominant variable region gene usage by gamma/delta T cell receptor-bearing cells in the adult thymus. J ExpMed 1988;168(3):1021-1040.
33. Grigoriadou K, Boucontet L, Pereira P.Most IL-4-producing gamma delta thymocytes of adultmice originate fromfetal precursors. J Immunol 2003;171(5):2413-2420.
34. Pereira P, Hermitte V, Lembezat MP, et al. Developmentally regulated and lineage-specific rearrangement of T cell receptor Valpha/delta gene segments. Eur J Immunol 2000;30(7):1988-1997.
35. Davodeau F, Peyrat MA,HalletMM, et al. Close correlation between Daudi andmycobacterial antigen recognition by human gamma delta T cells and expression of V9JPC1 gamma/V2DJC deltaencoded T cell receptors. J Immunol 1993;151(3):1214-1223.
36. Tanaka Y, Morita CT, Nieves E, et al. Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature 1995;375(6527):155-158.
37. Xiong N, Raulet DH. Development and selection of gammadelta T cells. Immunol Rev 2007;215:15-31.
38. Ceredig R, Rolink T. A positive look at double-negative thymocytes. Nat Rev Immunol 2002;2(11):888-897.
39. Michie AM, Zuniga-Pflucker JC. Regulation of thymocyte differentiation: pre-TCR signals and betaselection. Semin Immunol 2002;14(5):311-323.
40. Spits H. Development of alphabeta T cells in the human thymus. Nat Rev Immunol 2002;2(10):760-772.
41. von Boehmer H. Unique features of the pre-T-cell-receptor alpha-chain: not just a surrogate. Nat Rev Immunol 2005;5:571-577.
42. Kang J, Fehling HJ, Laplace C, et al. T cell receptor gamma gene regulatory sequences prevent the function of a novel TCRgamma/pTalpha pre-T cell receptor. Immunity 1998;8(6):713-721.
43. Fehling HJ, Krotkova A, Saint-Ruf C, von Boehmer H. Crucial role of the pre-T-cell receptor alpha gene in development of alpha beta but not gamma delta T cells. Nature 1995;375(6534): 795-798.
44. Ishida I, Verbeek S, Bonneville M, et al. T-cell receptor gamma delta and gamma transgenic mice suggest a role of a gamma gene silencer in the generation of alpha beta T cells. Proc Natl Acad Sci USA. 1990;87(8):3067-3071.
45. Hernandez-MunainC, SleckmanBP, Krangel MS.Adevelopmental switch fromTCRdelta enhancer to TCR alpha enhancer function during thymocytematuration. Immunity 1999;10(6):723-733.
46. Hayes SM, Li L, Love PE. TCR signal strength influences alphabeta/gammadelta lineage fate. Immunity 2005;22(5):583-593.
47. Haks MC, Lefebvre JM, Lauritsen JP, et al. Attenuation of gammadeltaTCR signaling efficiently diverts thymocytes to the alphabeta lineage. Immunity 2005;22(5):595-606.
48. Jensen KD, Su X, Shin S, et al. Thymic selection determines {gamma}{delta} T cell effector fate: Antigen-naive cellsmake interleukin-17 and antigen-experienced cellsmake interferon {gamma}. Immunity 2008;29:90-100.
49. Yamasaki S, Ishikawa E, Sakuma M, et al. Mechanistic basis of pre-T cell receptor-mediated autonomous signaling critical for thymocyte development. Nat Immunol 2006;7(1):67-75.
50. Pang SS, Berry R, Chen Z, et al.The structural basis for autonomous dimerization of the pre-T-cell antigen receptor. Nature 2010;467(7317):844-848.
51. Mahtani-Patching J, Neves JF, Pang DJ, et al. PreTCR and TCRgammadelta signal initiation in thymocyte progenitors does not require domains implicated in receptor oligomerization. Sci Signal 2011;4(182):ra47.
52. Capone M, Hockett RD, Jr., Zlotnik A. Kinetics of T cell receptor beta, gamma, and delta rearrangements during adult thymic development: T cell receptor rearrangements are present in CD44(+)CD25(+) Pro-T thymocytes. Proc Natl Acad Sci USA. 1998;95(21):12522-12527.
53. Livak F, Tourigny M, Schatz DG, Petrie HT. Characterization of TCR gene rearrangements during adultmurine T cell development. J Immunol 1999;162(5):2575-2580.
54. Kang J, Volkmann A, Raulet DH. Evidence that gammadelta versus alphabeta T cell fate determination is initiated independently of T cell receptor signaling. J Exp Med 2001;193(6): 689-698.
55. Spits H, Paliard X, Vandekerckhove Y, et al. Functional and phenotypic differences between CD4+ and CD4-T cell receptor-gamma delta clones from peripheral blood. J Immunol 1991;147(4):1180-1188.
56. Passoni L,Hoffman ES, Kim S, et al. Intrathymic delta selection events in gammadelta cell development. Immunity 1997;7(1):83-95.
57. Piliero LM, Sanford AN, McDonald-McGinn DM, et al. T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome. Blood 2004;103(3):1020-1025.
58. Borst J, van Dongen JJ. Repertoire selection of human gamma delta T cells. Res Immunol 1990;141(7):663-668.
59. Wucherpfennig KW, Liao YJ, Prendergast M, et al. Human fetal liver gamma/delta T cells predominantly use unusual rearrangements of the T cell receptor delta and gamma loci expressed on both CD4+CD8-and CD4-CD8-gamma/delta T cells. J ExpMed 1993 Feb;177(2):425-432.
60. Parker CM, Groh V, Band H, et al. Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J ExpMed 1990;171(5):1597-1612.
61. Melichar HJ, Narayan K, Der SD, et al. Regulation of gammadelta versus alphabeta T lymphocyte differentiation by the transcription factor SOX13. Science 2007;315(5809):230-233.
62. Rocha B, von Boehmer H. Peripheral selection of the T cell repertoire. Science 1991; 251(4998):1225-1228.
63. O'Brien RL, Born WK. gammadelta T cell subsets: a link between TCR and function? Semin Immunol 2010;22(4):193-198.
64. Narayan K, Sylvia KE,Malhotra N, et al. Intrathymic programming of effector fates in three molecularly distinct gammadelta T cell subtypes. Nat Immunol 2012;13(5):511-518.
65. Bluestone JA, Cron RQ, Barrett TA, et al. Repertoire development and ligand specificity of murine TCR gamma delta cells. Immunol Rev 1991;120:5-33.
66. Yachie A, Ueno Y, Takano N, et al. Developmental changes of double-negative (CD3+ 4-8-) T cells in human peripheral blood. Clin Exp Immunol 1989;76(2):258-261.
67. Zijlstra M, Bix M, Simister NE, et al. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 1990;344(6268):742-746.
68. Strominger JL. The gamma delta T cell receptor and class Ib MHC-related proteins: enigmatic molecules of immune recognition. Cell 1989;57(6):895-898.
69. Das H, Groh V, Kuijl C, et al.MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function. Immunity 2001;15(1):83-93.
70. Bertotto A, Gerli R, Spinozzi F, et al. Lymphocytes bearing the gamma delta T cell receptor in acute Brucella melitensis infection. Eur J Immunol 1993;23(5):1177-1180.
71. Maziarz RT, Groh V, PrendergastM, et al. Non-MHC-restricted target-cell lysis by a CD4-CD8-TCR alpha beta T-cell line, as well as by TCR gamma delta T-cell lines, results fromlymphokine-activated killing. Int J Cancer 1991;48(1):142-147.
72. Hiromatsu K, Yoshikai Y, Matsuzaki G, et al. A protective role of gamma/delta T cells in primary infection with Listeria monocytogenes inmice. J ExpMed 1992;175(1):49-56.
73. Ohga S,Yoshikai Y,Takeda Y, et al. Sequential appearance of gamma/delta-and alpha/beta-bearing T cells in the peritoneal cavity during an i.p. infection with Listeria monocytogenes. Eur J Immunol 1990;20(3):533-538.
74. Carding SR, AllanW, Kyes S, et al. Late dominance of the inflammatory process inmurine influenza by gamma/delta + T cells. J ExpMed 1990;172(4):1225-1231.
75. Tsuji M, Mombaerts P, Lefrancois L, et al. Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice. Proc Natl Acad Sci USA 1994;91(1):345-349.
76. van Oers NSC, Love PE, Shores EW,Weiss A. Regulation of TCR signal transduction in murine thymocytes bymultiple TCR zeta-chain signalingmotifs. J Immunol 1998;160(1):163-170.
77. Dave VP. Hierarchical role of CD3 chains in thymocyte development. Immunol Rev 2009;232: 22-33.
78. Call ME, Pyrdol J, Wucherpfennig KW. Stoichiometry of the T-cell receptor-CD3 complex and key intermediates assembled in the endoplasmic reticulum. EMBO J 2004;23:2348-2357.
79. Dave VP, Cao Z, Browne C, et al. CD3 delta deficiency arrests development of the alphabeta but not the gammadelta T cell lineage EMBO J 1997;16:1360-1370.
80. Hayes SM, Love PE. Stoichiometry of the murine gammadelta T cell receptor. J Exp Med 2006;203:47-52.
81. Siegers JM, Swamy M, Fernandez-Malave E, et al. Different composition of the human and the mouse gammadelta T cell receptor explains different phenotypesof CD3 gamma and CD3 delta immunodeficiencies. J ExpMed 2007;204:2537-2544.
82. Krangel MS, Bierer BE, Devlin P, et al. T3 glycoprotein is functional although structurally distinct on human T-cell receptor gamma T lymphocytes. Proc Natl Acad Sci USA 1987;84(11):3817-3821.
83. Smith-Garvin JE, Koretzky GA, Jordan MS. T cell activation. Annu Rev Immunol 2009;27:591-619.
84. Aivazian D, Stern LJ. Phosphorylation ofTcell receptor zeta is regulated by a lipid dependent folding transition. Nat Struct Biol 2000;7(11):1023-1026.
85. Xu C,Gagnon E, CallME, et al. Regulation of T cell receptor activation by dynamicmembrane binding of the CD3epsilon cytoplasmic tyrosine-basedmotif. Cell 2008;135(4):702-713.
86. Chan AC, IwashimaM, Turck CW, Weiss A. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. Cell 1992;71(4):649-662.
87. Molina TJ, Kishihara K, Siderovski DP, et al. Profound block in thymocyte development in mice lacking p56lck. Nature 1992;357(6374):161-164.
88. Fujise S,MatsuzakiG,Kishihara K, et al.The role of p56lck in the development of gamma deltaTcells and their function during an infection by Listeria monocytogenes. J Immunol 1996;157(1):247-254.
89. Laird RM, Hayes SM. Roles of the Src tyrosine kinases Lck and Fyn in regulating gammadeltaTCR signal strength. PLoS One 2010;5(1):e8899.
90. Negishi I, Motoyama N, Nakayama K, et al. Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature 1995;376(6539):435- 438.
91. Kadlecek TA, vanOers NS, Lefrancois L, et al. Differential requirements for ZAP-70 in TCR signaling and T cell development. J Immunol 1998;161(9):4688-4694.
92. Ohno H, Ono S, Hirayama N, et al. Preferential usage of the Fc receptor gamma chain in the T cell antigen receptor complex by gamma/delta T cells localized in epithelia. J Exp Med 1994;179(1):365-369.
93. Minoguchi K, Benhamou M, Swaim WD, et al. Activation of protein tyrosine kinase p72syk by Fc epsilon RI aggregation in rat basophilic leukemia cells. p72syk is aminor component but themajor protein tyrosine kinase of pp72. J Biol Chem 1994;269(24):16902-16908.
94. Cheng AM, Rowley B, Pao W, et al. Syk tyrosine kinase required for mouse viability and B-cell development. Nature 1995;378(6554):303-306.
95. Mallick-Wood CA, Pao W, Cheng AM, et al. Disruption of epithelial gamma delta T cell repertoires bymutation of the Syk tyrosine kinase. Proc Natl Acad Sci USA 1996;93(18):9704-9709.
96. Colucci F, Guy-Grand D, Wilson A, et al. A new look at Syk in alpha beta and gamma delta T cell development using chimeric mice with a low competitive hematopoietic environment. J Immunol 2000;164(10):5140-5145.
97. Fisch P,Meuer E, PendeD, et al. Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity. Eur J Immunol 1997;27(12):3368-3379.
98. Herberman RB, Nunn ME, Holden HT, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int J Cancer 1975;16(2):230-239.
99. O'Toole C, Stejskal V, Perlmann P, KarlssonM. Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector populationusing a surfacemarker. J ExpMed 1974;139(3):457-466.
100. Lake JP, Pierce CW, Kennedy JD. CD8+ alpha/beta or gamma/delta T cell receptor-bearing T cells from athymic nudemice are cytolytically active in vivo. J Immunol 1991;147(4):1121-1126.
101. Couzi L, Pitard V, Netzer S, et al. Common features of gammadelta T cells and CD8(+) alphabeta T cells responding to human cytomegalovirus infection in kidney transplant recipients. J Infect Dis 2009;200(9):1415-1424.
102. Lambert C, Genin C. CD3 bright lymphocyte population reveal gammadelta T cells. Cytometry B Clin Cytom 2004;61(1):45-53.
103. Aparicio P, Alonso JM, Toribio ML, et al. Isolation and characterization of (gamma, delta) CD4+ T cell clones derived fromhuman fetal liver cells. J ExpMed 1989;170(3):1009-1014.
104. Spinozzi F, Agea E, Bistoni O, et al. Local expansion of allergen-specific CD30+Th2-type gamma delta T cells in bronchial asthma.MolMed 1995;1(7):821-826.
105. Gerber DJ, Azuara V, Levraud JP, et al. IL-4-producing gamma delta T cells that express a very restricted TCR repertoire are preferentially localized in liver and spleen. J Immunol 1999;163(6):3076-3082.
106. Fowell DJ, Magram J, Turck CW, et al. Impaired Th2 subset development in the absence of CD4. Immunity 1997;6(5):559-569.
107. Wen L, Barber DF, Pao W, et al. Primary gamma delta cell clones can be defined phenotypically and functionally as Th1/Th2 cells and illustrate the association of CD4 with Th2 differentiation. J Immunol 1998;160(4):1965-1974.
108. Nawijn MC, Dingjan GM, Ferreira R, et al. Enforced expression of GATA-3 in transgenic mice inhibits Th1 differentiation and induces the formation of a T1/ST2-expressing Th2-committed T cell compartment in vivo. J Immunol 2001;167(2):724-732.
109. Heath VL, Showe L, Crain C, et al. Cutting edge: ectopic expression of the IL-12 receptor-beta 2 in developing and committedTh2cells does not affect the production of IL-4 or induce the production of IFN-gamma. J Immunol 2000;164(6):2861-2865.
110. Yin Z, Zhang DH,Welte T, et al. Dominance of IL-12 over IL-4 in gamma delta T cell differentiation leads to default production of IFN-gamma: failure to down-regulate IL-12 receptor beta 2-chain expression. J Immunol 2000;164(6):3056-3064.
111. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
112. Ferrick DA, Schrenzel MD, Mulvania T, et al. Differential production of interferon-gamma and interleukin-4 in response to Th1-and Th2-stimulating pathogens by gamma delta T cells in vivo. Nature 1995;373(6511):255-257.
113. Gershon RK. A disquisition on suppressor T cells. Transplant Rev 1975;26:170-185.
114. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of selftolerance causes various autoimmune diseases. J Immunol 1995;155(3):1151-1164.
115. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005;6(4):345-352.
116. Hayday A, Tigelaar R. Immunoregulation in the tissues by gammadelta T cells. Nat Rev Immunol 2003;3(3):233-242.
117. Traxlmayr MW, Wesch D, Dohnal AM, et al. Immune suppression by gammadelta T-cells as a potential regulatory mechanism after cancer vaccination with IL-12 secreting dendritic cells. J Immunother 2010;33(1):40-52.
118. Kang N, Tang L, Li X, et al. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human. Immunol Lett 2009;125(2):105-113.
119. Morita CT, Jin C, Sarikonda G, Wang H. Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev 2007;215:59-76.
120. Morita CT, Mariuzza RA, Brenner MB. Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system. Springer Semin Immunopathol 2000;22(3): 191-217.
121. Bukowski JF, Morita CT, Tanaka Y, et al. V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J Immunol 1995;154(3): 998-1006.
122. Belmant C, Espinosa E, Poupot R, et al. 3-Formyl-1-butyl pyrophosphate A novel mycobacterial metabolite-activating human gammadelta T cells. J Biol Chem 1999;274(45): 32079-32084.
123. Puan KJ, Jin C, Wang H, et al. Preferential recognition of a microbial metabolite by human Vgamma2Vdelta2 T cells. Int Immunol 2007;19(5):657-673.
124. Morita CT, Beckman EM, Bukowski JF, et al. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity 1995;3(4):495-507.
125. Fisch P,Malkovsky M, Kovats S, et al. Recognition by human V gamma 9/V delta 2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells. Science 1990;250(4985):1269-1273.
126. Barral DC, Brenner MB. CD1 antigen presentation: how it works. Nat Rev Immunol 2007;7(12):929-941.
127. Godfrey DI, MacDonald HR, Kronenberg M, et al. NKT cells: what's in a name? Nat Rev Immunol 2004;4(3):231-237.
128. Azuara V, Levraud JP, LembezatMP, Pereira P. A novel subset of adult gamma delta thymocytes that secretes a distinct pattern of cytokines and expresses a very restricted T cell receptor repertoire. Eur J Immunol 1997;27(2):544-553.
129. Kreslavsky T, Savage AK,Hobbs R, et al. TCR-inducible PLZF transcription factor required for innate phenotype of a subset of gammadelta T cells with restricted TCR diversity. Proc Natl Acad Sci USA 2009;106(30):12453-12458.
130. EidsonM,Wahlstrom J, Beaulieu AM, et al. Altered development of NKT cells, gammadelta T cells, CD8 T cells and NK cells in a PLZF deficient patient. PLoS One 2011;6(9):e24441.
131. Porcelli S, Brenner MB, Greenstein JL, et al. Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes. Nature 1989;341(6241):447-450.
132. Spada FM, Grant EP, Peters PJ, et al. Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J ExpMed 2000;191(6):937-948.
133. Faure F, Jitsukawa S, Miossec C, Hercend T. CD1c as a target recognition structure for human T lymphocytes: analysiswith peripheral blood gamma/delta cells.Eur J Immunol 1990;20(3):703-706.
134. Rock EP, Sibbald PR, Davis MM, Chien YH. CDR3 length in antigen-specific immune receptors. J ExpMed 1994;179(1):323-328.
135. Papageorgiou AC, Tranter HS, Acharya KR. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors. JMol Biol 1998;277(1):61-79.
136. Bukowski JF,Morita CT, BrennerMB. Recognition and destruction of virus-infected cells by human gamma delta CTL. J Immunol 1994;153(11):5133-5140.
137. Sciammas R, Johnson RM, Sperling AI, et al. Unique antigen recognition by a herpesvirus-specific TCR-gamma delta cell. J Immunol 1994;152(11):5392-5397.
138. O'Brien RL, Happ MP, Dallas A, et al. Stimulation of a major subset of lymphocytes expressing T cell receptor gamma delta by an antigen derived from Mycobacterium tuberculosis. Cell 1989;57(4):667-674.
139. Braud VM, Allan DS,McMichael AJ. Functions of nonclassicalMHC and non-MHC-encoded class Imolecules. Curr Opin Immunol 1999;11(1):100-108.
140. Lee N, Llano M, CarreteroM, et al. HLA-E is amajor ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 1998;95(9):5199-5204.
141. Romagnani C, Pietra G, Falco M, et al. Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells. Proc Natl Acad Sci USA 2002;99(17): 11328-11333.
142. Eghtesady P, Brorson KA, Cheroutre H, et al. Expression of mouse Tla region class I genes in tissues enriched for gamma delta cells. Immunogenetics 1992;36(6):377-388.
143. Crowley MP, Reich Z, Mavaddat N, et al. The recognition of the non-classical major histocompatibility complex (MHC) class I molecule, T10, by the gammadelta T cell, G8. J Exp Med 1997;185:1223-1230.
144. Crowley MP, Fahrer AM, Baumgarth N, et al. A population of murine gammadelta T cells that recognize an inducibleMHC class Ibmolecule. Science 2000;287:314-316.
145. Sandstrom A, Scharf L, McRae G, et al. gammadelta T cell receptors recognize the non-classical major histocompatibility complex (MHC) molecule T22 via conserved anchor residues in a MHC peptide-like fashion. J Biol Chem 2012;287(8):6035-6043.
146. SpitsH, Paliard X, Engelhard VH, de Vries JE. Cytotoxic activity and lymphokine production of T cell receptor (TCR)-alpha beta+ and TCR-gamma delta +cytotoxic T lymphocyte (CTL) clones recognizing HLA-A2 and HLA-A2mutants. Recognition of TCR-gamma delta+CTL clones is affected by mutations at positions 152 and 156. J Immunol 1990;144(11):4156-4162.
147. Ciccone E, Viale O, Pende D, et al. Specificity of human T lymphocytes expressing a gamma/delta T cell antigen receptor. Recognition of a polymorphic determinant of HLA class I molecules by a gamma/delta clone. Eur J Immunol 1989;19(7):1267-1271.
148. Del Porto P, D'AmatoM, Fiorillo MT, et al. Identification of a novel HLA-B27 subtype by restriction analysis of a cytotoxic gamma delta T cell clone. J Immunol 1994;153(7):3093-3100.
149. Holoshitz J, Vila LM, Keroack BJ, et al. Dual antigenic recognition by cloned human gamma delta T cells. J Clin Invest 1992;89(1):308-314.
150. Flament C, Benmerah A, Bonneville M, et al. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta. J Immunol 1994;153(7):2890-2904.
151. Mami-Chouaib F, Flament C, Asselin-Paturel C, et al. TCR alpha/beta and TCR gamma/delta CD4-/CD8-HLA-DR alloreactive CTL clones do not use Fas/Fas ligand pathway to lyse their specific target cells. Hum Immunol 1996;51(1):13-22.
152. Schild H,MavaddatN, Litzenberger C, et al.Thenature ofmajor histocompatibility complex recognition by gamma delta T cells. Cell 1994;76(1):29-37.
153. Tschachler E, Schuler G, Hutterer J, et al. Expression ofThy-1 antigen by murine epidermal cells. J Invest Dermatol 1983;81(3):282-285.
154. Bergstresser PR, Tigelaar RE, Dees JH, Streilein JW.Thy-1 antigen-bearing dendritic cells populate murine epidermis. J Invest Dermatol 1983;81(3):286-288.
155. Koning F, Stingl G, Yokoyama WM, et al. Identification of a T3-associated gamma delta T cell receptor onThy-1 +dendritic epidermal Cell lines. Science 1987;236(4803):834-837.
156. Havran WL, Poenie M, Tigelaar RE, et al. Phenotypic and functional analysis of gamma delta T cell receptor-positivemurine dendritic epidermal clones. J Immunol 1989;142(5):1422-1428.
157. Asarnow DM, Kuziel WA, Bonyhadi M, et al. Limited diversity of gamma delta antigen receptor genes ofThy-1+ dendritic epidermal cells. Cell 1988;55(5):837-847.
158. Lafaille JJ, DeCloux A, Bonneville M, et al. Junctional sequences of T cell receptor gamma delta genes: implications for gamma delta T cell lineages and for a novel intermediate of V-(D)-J joining. Cell 1989;59(5):859-870.
159. Bonneville M, Itohara S, Krecko EG, et al. Transgenic mice demonstrate that epithelial homing of gamma/delta T cells is determined by cell lineages independent of T cell receptor specificity. J Exp Med 1990;171(4):1015-1026.
160. Ferrero I, Wilson A, Beermann F, et al. T cell receptor specificity is critical for the development of epidermal gammadelta T cells. J ExpMed 2001;194(10):1473-1483.
161. Lewis JM, Girardi M, Roberts SJ, et al. Selection of the cutaneous intraepithelial gammadelta+ T cell repertoire by a thymic stromal determinant. Nat Immunol 2006;7(8):843-850.
162. Mallick-Wood CA, Lewis JM, Richie LI, et al. Conservation of T cell receptor conformation in epidermal gammadelta cells with disrupted primary Vgamma gene usage. Science 1998;279(5357):1729-1733.
163. Boyden LM, Lewis JM, Barbee SD, et al. Skint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal gammadelta T cells. Nat Genet 2008;40(5):656-662.
164. Barbee SD,WoodwardMJ, Turchinovich G, et al. Skint-1 is a highly specific, unique selecting component for epidermal T cells. Proc Natl Acad Sci USA 2011;108(8):3330-3335.
165. Turchinovich G, Hayday AC. Skint-1 identifies a common molecular mechanism for the development of interferon-gamma-secreting versus interleukin-17-secreting gammadelta T cells. Immunity 2011;35(1):59-68.
166. Jin Y, Xia M, Saylor CM, et al. Cutting edge: Intrinsic programming of thymic gammadeltaT cells for specific peripheral tissue localization. J Immunol 2010;185(12):7156-7160.
167. Havran WL, Chien YH, Allison JP. Recognition of self antigens by skin-derived T cells with invariant gamma delta antigen receptors. Science 1991;252(5011):1430-1432.
168. Jameson J, Havran WL. Skin gammadelta T-cell functions in homeostasis and wound healing. Immunol Rev 2007;215:114-122.
169. GirardiM, Oppenheim DE, Steele CR, et al. Regulation of cutaneousmalignancy by gammadelta T cells. Science 2001;294(5542):605-609.
170. Boismenu R, Feng L, Xia YY, et al. Chemokine expression by intraepithelial gamma delta T cells. Implications for the recruitment of inflammatory cells to damaged epithelia. J Immunol 1996;157(3):985-992.
171. Jameson JM, Cauvi G, Witherden DA, Havran WL. A keratinocyte-responsive gamma delta TCR is necessary for dendritic epidermal T cell activation by damaged keratinocytes and maintenance in the epidermis. J Immunol 2004;172(6):3573-3579.
172. Sharp LL, Jameson JM, Cauvi G, Havran WL. Dendritic epidermal T cells regulate skin homeostasis through local production of insulin-like growth factor 1. Nat Immunol 2005;6(1):73-79.
173. BoismenuR,Havran WL.Modulation of epithelial cell growth by intraepithelial gamma deltaTcells. Science 1994;266(5188):1253-1255.
174. Jameson J, Ugarte K, Chen N, et al. A role for skin gammadelta T cells in wound repair. Science 2002;296(5568):747-749.
175. Jameson JM, Cauvi G, Sharp LL, et al. Gammadelta T cell-induced hyaluronan production by epithelial cells regulates inflammation. J ExpMed 2005;201(8):1269-1279.
176. Witherden DA,Watanabe M, Garijo O, et al.The CD100 Receptor Interactswith Its Plexin B2 Ligand to Regulate Epidermal gammadelta T Cell Function. Immunity 2012;37(2):314-325.
177. Bonneville M. Semaphorins: New Cues for Skin Healing by gammadelta T Cells. Immunity 2012;37(2):194-196.
178. Groh V, Porcelli S, Fabbi M, et al. Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system. J Exp Med 1989;169(4):1277-1294.
179. Foster CA, Yokozeki H, Rappersberger K, et al. Human epidermal T cells predominantly belong to the lineage expressing alpha/beta T cell receptor. J ExpMed 1990;171(4):997-1013.
180. Groh V, Fabbi M, Hochstenbach F, et al. Double-negative (CD4-CD8-) lymphocytes bearing T-cell receptor alpha and beta chains in normal human skin. Proc Natl Acad Sci USA 1989;86(13):5059-5063.
181. Spetz AL, Strominger J, Groh-Spies V. T cell subsets in normal human epidermis. Am J Pathol 1996;149(2):665-674.
182. Goodman T, Lefrancois L. Expression of the gamma-delta T-cell receptor on intestinal CD8+ intraepithelial lymphocytes. Nature 1988;333(6176):855-858.
183. Bonneville M, Janeway CA, Jr., Ito K, et al. Intestinal intraepithelial lymphocytes are a distinct set of gamma delta T cells. Nature 1988;336(6198):479-481.
184. Groh V, Bahram S, Bauer S, et al. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 1996;93(22):12445-12450.
185. Stephens HA. MICA and MICB genes: can the enigma of their polymorphism be resolved? Trends Immunol 2001;22(7):378-385.
186. Li P,Morris DL, Willcox BE, et al. Complex structure of the activating immunoreceptor NKG2D and itsMHC class I-like ligandMICA. Nat Immunol 2001;2(5):443-451.
187. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHCmolecules by intestinal epithelial gammadelta T cells. Science 1998;279(5357):1737-1740.
188. Groh V, Rhinehart R, Secrist H, et al. Broad tumor-associated expression and recognition by tumorderived gamma delta T cells of MICA andMICB. Proc Natl Acad Sci USA 1999;96(12):6879-6884.
189. Nedellec S, Sabourin C, Bonneville M, Scotet E. NKG2D costimulates human V gamma 9V delta 2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCRinduced calcium and transduction signals. J Immunol 2010;185(1):55-63.
190. Rincon-Orozco B, Kunzmann V,Wrobel P, et al. Activation of V gamma 9V delta 2 T cells byNKG2D. J Immunol 2005;175(4):2144-2151.
191. Bucy RP, Chen CL, Cooper MD. Tissue localization and CD8 accessory molecule expression of T gamma delta cells in humans. J Immunol 1989;142(9):3045-3049.
192. HoltmeierW, Chowers Y, Lumeng A, et al.The delta T cell receptor repertoire in human colon and peripheral blood is oligoclonal irrespective of V region usage. J Clin Invest 1995;96(2):1108-1117.
193. Russell GJ, Winter HS, Fox VL, Bhan AK. Lymphocytes bearing the gamma delta T-cell receptor in normal human intestine and celiac disease. Hum Pathol 1991;22(7):690-694.
194. LaSalle JM, Toneguzzo F, Saadeh M, et al. T-cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction. Differential MHC requirements for superantigen and autoantigen. J Immunol 1993;151(2):649-657.
195. Hosken NA, Bevan MJ. Defective presentation of endogenous antigen by a cell line expressing class Imolecules. Science 1990;248(4953):367-370.
196. Brandes M, Willimann K, Moser B. Professional antigen-presentation function by human gammadelta T Cells. Science 2005;309(5732):264-268.
197. Himoudi N, Morgenstern DA, Yan M, et al. Human gammadelta T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells. J Immunol 2012;188(4):1708-1716.
198. Wu Y,Wu W,Wong WM, et al. Human gamma delta T cells: a lymphoid lineage cell capable of professional phagocytosis. J Immunol 2009;183(9):5622-5629.
199. BrandesM,Willimann K, Bioley G, et al.Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses. Proc Natl Acad Sci USA 2009;106(7):2307-2312.
200. Carding SR, Egan PJ.Gammadelta T cells: functional plasticity and heterogeneity.Nat RevImmunol 2002;2(5):336-345.
201. Billington WD. The immunological problem of pregnancy: 50 years with the hope of progress. A tribute to PeterMedawar. J Reprod Immunol 2003;60(1):1-11.
202. Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol 2006;6(8):584-594.
203. Apps R,Murphy SP, Fernando R, et al. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 2009;127(1):26-39.
204. Favier B, Lemaoult J, Lesport E, Carosella ED. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse. FASEB J 2010;24(3):689-699.
205. Rajagopalan S, Long EO. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J ExpMed 1999;189(7):1093-1100.
206. Shiroishi M, Kuroki K, Rasubala L, et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci USA 2006;103(44):16412-16417.
207. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002 Sep;2(9):656-663.
208. Itohara S, Farr AG, Lafaille JJ, et al. Homing of a gamma delta thymocyte subset with homogeneous T-cell receptors tomucosal epithelia. Nature 1990;343(6260):754-757.
209. Nandi D, Allison JP. Phenotypic analysis and gamma delta-T cell receptor repertoire of murine T cells associated with the vaginal epithelium. J Immunol 1991;147(6):1773-1778.
210. Mincheva-Nilsson L, Baranov V, YeungMM,et al. Immunomorphologic studies of human deciduaassociated lymphoid cells in normal early pregnancy. J Immunol 1994;152(4):2020-2032.
211. Heyborne KD, Cranfill RL, Carding SR, et al. Characterization of gamma delta T lymphocytes at the maternal-fetal interface. J Immunol 1992;149(9):2872-2878.
212. Hayakawa S, ShiraishiH, Saitoh S, Satoh K. Decidua as a site of extrathymic V gamma I T-cell differentiation. Am J Reprod Immunol 1996;35(3):233-238.
213. Barakonyi A, Kovacs KT, Miko E, et al. Recognition of nonclassical HLA class I antigens by gamma delta T cells during pregnancy. J Immunol 2002;168(6):2683-2688.
214. Heyborne K, Fu YX, Nelson A, et al. Recognition of trophoblasts by gamma delta T cells. J Immunol 1994;153(7):2918-2926.
215. Leavy O.Therapeutic antibodies: past, present and future. Nat Rev Immunol 2010;10(5):297.
216. Kunzmann V, Kretzschmar E, Herrmann T, Wilhelm M. Polyinosinic- polycytidylic acid-mediated stimulation of human gammadelta T cells via CD11c dendritic cell-derived type I interferons. Immunology 2004;112(3):369-377.
217. Wesch D, Beetz S, Oberg HH, et al. Direct costimulatory effect of TLR3 ligand poly(I:C) on human gamma delta T lymphocytes. J Immunol 2006;176(3):1348-1354.
218. Malissen B, Ewbank JJ. "TaiLoRing" the response of dendritic cells to pathogens. Nat Immunol 2005;6(8):749-750.
219. Meraviglia S, Caccamo N, Guggino G, et al. Optimizing tumor-reactive gammadelta T cells for antibody-based cancer immunotherapy. CurrMolMed 2010;10(8):719-726.
220. Ismaili J,Olislagers V, Poupot R, et al.Human gamma delta T cells induce dendritic cellmaturation. Clin Immunol 2002;103(3):296-302.
221. Casetti R, Martino A. The plasticity of gamma delta T cells: innate immunity, antigen presentation and new immunotherapy. CellMol Immunol 2008;5(3):161-170.
222. Martino A, Poccia F. Gamma delta T cells and dendritic cells: close partners and biological adjuvants for new therapies. CurrMolMed 2007;7(7):658-673.
223. Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ. Dendritic cell immunotherapy: mapping the way. NatMed 2004;10(5):475-480.
224. Shinoda H, Adamek G, Felix R, et al. Structure-activity relationships of various bisphosphonates. Calcif Tissue Int 1983;35(1):87-99.
225. Gnant M, Mlineritsch B, Schippinger W, et al. Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl JMed 2009;360(7):679-691.
226. Miyagawa F, Tanaka Y, Yamashita S, Minato N. Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human gamma delta T cells by aminobisphosphonate antigen. J Immunol 2001;166(9):5508-5514.
227. Benzaid I,Monkkonen H, Stresing V, et al. High phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vgamma9Vdelta2 T-cell chemotaxis and cytotoxicity in vivo. Cancer Res 2011;71(13):4562-4572.
228. Maniar A, Zhang X, Lin W, et al. Human gammadelta T lymphocytes induce robust NK cellmediated antitumor cytotoxicity through CD137 engagement. Blood 2010;116(10):1726-1733.
229. Sato K, Kimura S, Segawa H, et al. Cytotoxic effects of gammadelta T cells expanded ex vivo by a third generation bisphosphonate for cancer immunotherapy. Int J Cancer 2005;116(1):94-99.
230. Martinet L, Poupot R, Fournie JJ. Pitfalls on the roadmap to gammadelta T cell-based cancer immunotherapies. Immunol Lett 2009;124(1):1-8.
231. Dieli F, Vermijlen D, Fulfaro F, et al. Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Cancer Res 2007;67(15):7450-7457.
232. Nicol AJ, Tokuyama H, Mattarollo SR, et al. Clinical evaluation of autologous gamma delta T cellbased immunotherapy formetastatic solid tumours. Br J Cancer 2011;105(6):778-786.
233. Agrati C, D'Offizi G, Gougeon ML, et al. Innate gamma/delta T-cells during HIV infection: Terra relatively Incognita in novel vaccination strategies? AIDS Rev 2011;13(1):3-12.
234. Bjorkman PJ, Saper MA, SamraouiB, et al. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987;329(6139):506-512.
235. Brown JH, Jardetzky TS, Gorga JC, et al.Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993;364(6432):33-39.